ARTICLE | Clinical News
Hextend: Phase II ongoing
December 11, 2006 8:00 AM UTC
BTIM disclosed that partner Summit is running an open-label, Japanese Phase II trial in an undisclosed number of subjects. BTIM and Summit partnered in 2004 and in 2005 Summit granted Maruishi a subli...